IN2015DN04161A - - Google Patents

Download PDF

Info

Publication number
IN2015DN04161A
IN2015DN04161A IN4161DEN2015A IN2015DN04161A IN 2015DN04161 A IN2015DN04161 A IN 2015DN04161A IN 4161DEN2015 A IN4161DEN2015 A IN 4161DEN2015A IN 2015DN04161 A IN2015DN04161 A IN 2015DN04161A
Authority
IN
India
Prior art keywords
drug
inner core
relates
present
osmotic
Prior art date
Application number
Other languages
English (en)
Inventor
Varinder Kumar
Shavej Ahmad
Romi Barat Singh
Ajay Kumar Singla
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Priority to IN4161DEN2015 priority Critical patent/IN2015DN04161A/en
Publication of IN2015DN04161A publication Critical patent/IN2015DN04161A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/005—Coating of tablets or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
IN4161DEN2015 2012-10-16 2013-10-15 IN2015DN04161A (sr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN4161DEN2015 IN2015DN04161A (sr) 2012-10-16 2013-10-15

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN3222DE2012 2012-10-16
IN4161DEN2015 IN2015DN04161A (sr) 2012-10-16 2013-10-15
PCT/IB2013/059374 WO2014060952A1 (en) 2012-10-16 2013-10-15 Osmotic floating tablets

Publications (1)

Publication Number Publication Date
IN2015DN04161A true IN2015DN04161A (sr) 2015-10-16

Family

ID=49880871

Family Applications (1)

Application Number Title Priority Date Filing Date
IN4161DEN2015 IN2015DN04161A (sr) 2012-10-16 2013-10-15

Country Status (4)

Country Link
US (1) US9861585B2 (sr)
EP (1) EP2908803A1 (sr)
IN (1) IN2015DN04161A (sr)
WO (1) WO2014060952A1 (sr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017058869A1 (en) 2015-09-29 2017-04-06 Acorda Therapeutics, Inc. Sustained release compositions of 4-aminopyridine
CN107753457A (zh) * 2017-10-26 2018-03-06 青岛黄海制药有限责任公司 一种具有膨胀片芯的硝苯地平微孔渗透泵包芯片及其制备方法
CN107961225A (zh) * 2017-12-07 2018-04-27 中国药科大学 一种普瑞巴林微孔渗透泵片及其制备方法
US11147767B2 (en) * 2019-02-25 2021-10-19 Rubicon Research Private Limited Gastroretentive formulations
CN109966258A (zh) * 2019-04-26 2019-07-05 安阳天助药业有限责任公司 一种可防止有色片剂褪色的包衣预混剂
WO2020230089A1 (en) 2019-05-14 2020-11-19 Clexio Biosciences Ltd. Treatment of nocturnal symptoms and morning akinesia in subjects with parkinson's disease
EP3760190B1 (en) 2019-07-03 2023-05-24 Alvogen, Inc. Controlled-release tablets of pregabalin, method of making, and method of use thereof
CN112137984B (zh) * 2020-10-30 2023-02-03 四川制药制剂有限公司 头孢克洛胶囊及其制备工艺
WO2022195476A1 (en) 2021-03-15 2022-09-22 Clexio Biosciences Ltd. Gastroretentive devices for assessment of intragastric conditions

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
GB9710699D0 (en) 1997-05-24 1997-07-16 Danbiosyst Uk Gastro-retentive controlled release system
US7029701B2 (en) 2000-09-11 2006-04-18 Andrx Pharmaceuticals, Llc Composition for the treatment and prevention of ischemic events
US20030175349A1 (en) 2001-01-30 2003-09-18 Council Of Scientific And Industrial Research Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient
US20030091630A1 (en) 2001-10-25 2003-05-15 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
US20050031688A1 (en) 2003-08-04 2005-02-10 Ayala William J. Positive wakeup pharmaceutical sleep system with compatible pre-bedtime administration
NL2000281C2 (nl) 2005-11-02 2007-08-07 Pfizer Prod Inc Vaste farmaceutische samenstellingen die pregabaline bevatten.
US20070184115A1 (en) * 2005-12-30 2007-08-09 Biovail Laboratories International S.R.L. Modified release formulations of tramadol and uses thereof
EP2032124A1 (en) * 2006-06-27 2009-03-11 Biovail Laboratories International Srl Multiparticulate osmotic delivery system
US8454993B2 (en) 2007-11-23 2013-06-04 Lupin Limited Controlled release pharmaceutical compositions of pregabalin
US20120208773A1 (en) * 2008-08-12 2012-08-16 Valeant International (Barbados) Srl Pharmaceutical compositions with tetrabenazine
US20100112052A1 (en) * 2008-10-31 2010-05-06 Vincent Chen Osmotic tablet with a compressed outer coating
WO2010143052A1 (en) 2009-06-12 2010-12-16 Micro Labs Limited Novel pharmaceutical compositions containing pregabalin
WO2011151708A1 (en) 2010-06-01 2011-12-08 Rubicon Research Private Limited Gastroretentive dosage forms of gaba analogs

Also Published As

Publication number Publication date
US9861585B2 (en) 2018-01-09
EP2908803A1 (en) 2015-08-26
US20150231084A1 (en) 2015-08-20
WO2014060952A1 (en) 2014-04-24

Similar Documents

Publication Publication Date Title
IN2015DN04161A (sr)
CO2017012362A2 (es) Formas de dosificación sólida que comprenden palbociclib, un ácido hidrosoluble y un portador farmacéuticamente aceptable y métodos para su produccion y uso
PH12016500121A1 (en) Pharmaceutical tablet comprising acetylsalicyclic acid and clopidogrel
MX350875B (es) Formas de dosificacion farmaceutica de liberacion controlada.
EP4249055A3 (en) Tofacitinib oral sustained release dosage forms
TW201711676A (en) Ferric citrate dosage forms
PH12015501015A1 (en) Pharmaceutical compositions comprising hydromorphone and naloxone
WO2014114255A3 (zh) 一种定位速释生物粘附剂及应用
CL2012003523A1 (es) Método para la preparación de una composición farmacéutica que contiene un portador de oxígeno termoestable; composicion farmaceutica que contiene un portador de oxigeno altamente purificado y termoestable.
MX340188B (es) Elaboracion de granulos sin activos y tabletas que comprenden los mismos.
HUE060093T2 (hu) Gyógyszerészeti tablettakészítmény az állatgyógyászati ágazat számára, eljárás annak elõállítására és annak alkalmazása
CA2863376A1 (en) Gastroretentive tablets
MX2020013162A (es) Comprimidos de liberacion inmediata que contienen un farmaco y procesos para formar los comprimidos.
PH12014501408A1 (en) Immediate release multi unit pellet system
TN2012000507A1 (en) Enteric tablet
IN2014DN06965A (sr)
GEP201706743B (en) Oral formulation for the treatment of cardiovascular diseases
PH12014502325B1 (en) Sustained release tablet containing levodropropizine and method for preparing same
EA201891886A1 (ru) Содержащая прегабалин трехслойная таблетка с замедленным высвобождением для перорального приема
IN2013MU01111A (sr)
RS20130034A1 (en) PHARMACEUTICAL MIXTURE FOR LONG TERMETASIDINE RELEASE
HK1220113A1 (zh) 藥物軟明膠膠囊劑型
EA201270269A1 (ru) Фармацевтическая таблетка, содержащая розувастатин кальция
EP3065737A4 (en) Oral pharmaceutical form for preventing vascular diseases, tablet as pharmaceutical form and gelatin capsule as pharmaceutical form
MX346466B (es) Comprimido de tipo liberacion controlada que contiene aceclofenaco.